Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AbbVie Inc. Director's Dealing 2024

Sep 30, 2024

29755_dirs_2024-09-30_57c018c2-162b-4ffd-b4e6-c6f464358d2c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2024-09-24

Reporting Person: SALEKI-GERHARDT AZITA (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-09-24 Common Stock, $0.01 par value G 25630 Disposed 194348 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, $0.01 par value 2322 Indirect
Common Stock, $0.01 par value 3873 Indirect

Footnotes

F1: Balance in AbbVie Savings program as of January 31, 2024.

F2: The reporting person disclaims beneficial ownership of all securities held by her spouse.